Skip to main content

Stories by Coco Ballantyne

FDA advisory panel strikes down common asthma drugs

An advisory panel yesterday recommended that the Food and Drug Administration (FDA) strip two popular asthma drugs—GlaxoSmithKline's Serevent and Schering Plough's Foradil—from the market...

December 12, 2008 — Coco Ballantyne

Diabetes Rx ups bone fracture risk

A new study indicates that drugs called thiazolidinediones used to control blood sugar in patients with type 2 diabetes may do more harm than good. Scientists report in the Canadian Medical Association Journal (CMAJ) that women who take the meds have reduced spine and hip bone density and have double the risk of fracturing bones if they're on the pills for more than a year...

December 10, 2008 — Coco Ballantyne

The biggest loser: Buying weight loss

Seems money trumps health when it comes to losing weight. A new study published in the Journal of the American Medical Association today found that people were more likely to stick to weight-loss programs if they were offered cash incentives...

December 10, 2008 — Coco Ballantyne

What is Guinea Worm Disease?

Disease-fighting crusaders say they are on the cusp of eradicating Guinea worm disease, which can be checked with simple public health interventions

December 8, 2008 — Coco Ballantyne

Losing Scents

A pheromone-gene link raises questions about the decline of nasal know-how

November 19, 2007 — Coco Ballantyne
Scroll To Top